Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Dec;21(12):1785-9.
doi: 10.1007/s00467-006-0284-2. Epub 2006 Sep 7.

EPO: renoprotection beyond anemia correction

Danilo Fliser  1 , Ferdinand H Bahlmann, Hermann Haller
Affiliations
Review

EPO: renoprotection beyond anemia correction

Danilo Fliser et al. Pediatr Nephrol. 2006 Dec.

Abstract

Until recently the major physiological function of erythropoietin (EPO) was thought to be the induction of erythropoiesis. However, a growing body of evidence indicates that EPO has tissue-protective properties and prevents ischemia induced tissue damage in several organs including the kidney. A pivotal intracellular pathway mediating the beneficial effects of EPO is the activation of Akt, i.e. serine/threonine protein kinase B. As a result, Akt phosphorylates the proapoptotic factor Bad, which in turn causes inhibition of programmed cell death (apoptosis). In the present article we review data on the non-hematological effects of recombinant human EPO (rHuEPO) in different experimental settings of acute and chronic kidney injury, and discuss clinical renoprotective strategies with rHuEPO or analogues substances that are not related to anemia correction.

PubMed Disclaimer

References

    1. Blood. 2000 May 1;95(9):2983-9 - PubMed
    1. FASEB J. 2003 Sep;17(12):1754-5 - PubMed
    1. Kidney Int. 2004 Aug;66(2):753-60 - PubMed
    1. Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14907-12 - PubMed
    1. Nat Rev Neurosci. 2005 Jun;6(6):484-94 - PubMed

Publication types